Healthcare ❯Pharmaceuticals
Clinical Trials Drug Development Vertex Pharmaceuticals
The acquisition aims to bolster Eli Lilly's pipeline with Morphic's experimental treatments for inflammatory bowel disease and other chronic conditions.
